title: High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates.
abstract: Mannose-binding lectin (MBL) is a component of innate immunity and thus particularly important in neonates in whom adaptive immunity is not yet completely developed. Promoter polymorphisms and structural exon-1 mutations in the MBL2 gene cause reduced or deficient MBL plasma concentrations. The aim of our study was to determine the prevalence of MBL deficiency in neonates admitted to the neonatal intensive care unit (NICU). Eighty-five NICU patients (69 premature) were included in the study. We measured MBL concentrations in umbilical cord and neonatal blood within 24 h after birth by ELISA technique. MBL2 genotypes (n = 67) were determined by Taqman analysis. MBL concentrations were measured longitudinally during three weeks in 26 premature neonates. The association between pre- and intra-partum clinical data and MBL concentrations was investigated. At birth, 29 (42%) premature and six (38%) term neonates had MBL plasma concentrations < or = 0.7 microg/ml which was regarded as deficient. Twenty-one (38%) premature and four (36%) term neonates had variant MBL2 haplotypes, corresponding to exon-1 mutations and the LXPA haplotype. MBL concentrations increased over time in neonates with wild-type MBL2 haplotypes, but not in neonates with variant haplotypes. Low MBL plasma concentrations were related to lower gestational age and variant MBL2 haplotypes. Umbilical cord and neonatal MBL plasma concentrations appeared to be similar. In conclusion, almost half of our NICU patients, especially the premature ones, were MBL-deficient at birth. These infants may be at increased risk of neonatal infections. MBL concentration can reliably be measured in umbilical cord blood and it is positively correlated with gestational and postnatal age.
authors.affiliation: Emma Children's Hospital, Academic Medical Centre (AMC), Amsterdam, The Netherlands. f.n.frakking@amc.uva.nl
authors.forename: F N J
authors.initials: FN
authors.lastname: Frakking
authors.forename: N
authors.initials: N
authors.lastname: Brouwer
authors.forename: D
authors.initials: D
authors.lastname: Zweers
authors.forename: M P
authors.initials: MP
authors.lastname: Merkus
authors.forename: T W
authors.initials: TW
authors.lastname: Kuijpers
authors.forename: M
authors.initials: M
authors.lastname: Offringa
authors.forename: K M
authors.initials: KM
authors.lastname: Dolman
mesh_terms: D019540:Area Under Curve; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005091:Exons; D005260:Female; D005312:Fetal Blood / Q000737:chemistry*; D005865:Gestational Age; D006239:Haplotypes; D006801:Humans; D007113:Immunity, Innate; D007231:Infant, Newborn; D007234:Infant, Premature / Q000378:metabolism*; D008137:Longitudinal Studies; D008297:Male; D037601:Mannose-Binding Lectin / Q000097:blood / Q000172:deficiency* / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic
chemical_list: D037601:Mannose-Binding Lectin